Business Context and Reporting Period
This Form 8-K was filed by pSivida Corp. on February 8, 2017. The filing reports the entry into a material definitive agreement to establish an "at-the-market" equity offering program. Note: The request metadata references "Eyepoint, Inc.," but the filing text explicitly identifies the registrant as pSivida Corp.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization to raise capital:
- Maximum Offering Size: Up to $20,000,000 in aggregate offering price.
- Commission Rate: Up to 3.0% of gross proceeds from each sale.
- Underwriter: FBR Capital Markets & Co.
Material Changes
The material change reported is the execution of an At Market Issuance Sales Agreement with FBR Capital Markets & Co. This agreement allows the company to sell shares of its common stock (par value $0.001) through ordinary brokerage transactions on The NASDAQ Global Market or other permitted methods. The company retains the right to suspend offers at any time and has no obligation to sell any shares.
Guidance, Outlook, and Risks
Outlook and Management Commentary: The filing does not contain forward-looking financial guidance or management commentary regarding operational performance. The program is intended to provide flexibility in raising capital as market conditions permit.
Risks and Contingencies:
- Sales are subject to the company's instructions and market conditions.
- The offering will terminate upon the sale of all shares or termination of the agreement by either party.
- Sales are subject to applicable securities laws and registration requirements.
Investor Verification Checklist
- Verify the exact number of shares authorized for sale under the $20,000,000 cap based on the current stock price.
- Review the attached Exhibit 10.1 (Sales Agreement) for specific termination clauses and indemnification details.
- Confirm the status of the underlying shelf registration statement (Form S-3, File No. 333-208115).
- Monitor future filings for actual sales volumes and proceeds generated under this program.